Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature | |
Zhou Weixun; Huang Yan; Lai Jinping; Lu Jun; Feely Michael; Liu Xiuli | |
2018 | |
卷号 | 11期号:3页码:174-188 |
关键词 | Anti-tumor necrosis factor-α Colitis Crohn’s disease Etanercept Inflammatory bowel disease Infliximab Programmed cell death protein 1 Ulcerative colitis |
ISSN号 | 1918-2805 |
DOI | 10.14740/gr1041w |
URL标识 | 查看原文 |
收录类别 | PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6358270 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhou Weixun,Huang Yan,Lai Jinping,et al. Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature[J],2018,11(3):174-188. |
APA | Zhou Weixun,Huang Yan,Lai Jinping,Lu Jun,Feely Michael,&Liu Xiuli.(2018).Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.,11(3),174-188. |
MLA | Zhou Weixun,et al."Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature".11.3(2018):174-188. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论